MedPath

Tetrahydropalmatine

Generic Name
Tetrahydropalmatine
Drug Type
Small Molecule
Chemical Formula
C21H25NO4
CAS Number
483-14-7
Unique Ingredient Identifier
3X69CO5I79

Overview

Tetrahydropalmatine is under investigation in clinical trial NCT02118610 (Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity).

Background

Tetrahydropalmatine is under investigation in clinical trial NCT02118610 (Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity).

Indication

用于胃肠及肝胆系统内科疾病所引起的钝痛,一般性头痛以及脑震荡后头痛等;也可用于月经痛及分娩止痛。

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath